Manina Medtech
Detecting uterine readiness for embryo implantation non-invasively and instantly, on the day of embryo transfer, boosting IVF success.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
$325k | Grant | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| % profit margin | 3141 % | - |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
More about Manina Medtech
EditManina Medtech is a healthcare technology company focused on improving the success rates of In Vitro Fertilization (IVF) treatments. Its innovative solution, SEEDCHRONY, is a first-in-class medical device that non-invasively and instantly detects uterine readiness for embryo implantation on embryo transfer day. This breakthrough technology aims to make IVF treatments faster, healthier, and more affordable by reducing repeated trial-and-error transfers and supporting natural cycles for better pregnancy and neonatal outcomes.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads